2021-01-04 |
13G/A
|
EIGR / Eiger BioPharmaceuticals, Inc.
|
|
1,236,368 |
0 |
|
|
|
2021-01-04 |
13G/A
|
LJPC / La Jolla Pharmaceutical Co.
|
|
2,688,068 |
0 |
|
|
|
2020-06-23 |
13D/A
|
SSKN / STRATA Skin Sciences, Inc.
|
|
2,170,757 |
1,529,392 |
|
|
|
2020-02-25 |
13G/A
|
TLGT / Teligent Inc
|
|
0 |
0 |
|
|
|
2020-02-14 |
13G/A
|
US64052L1061 / Neos Therapeutics, Inc.
|
|
2,618,819 |
0 |
|
|
|
2020-02-13 |
13G/A
|
TVTX / Travere Therapeutics, Inc.
|
|
2,077,432 |
0 |
|
|
|
2020-02-13 |
13G/A
|
EIGR / Eiger BioPharmaceuticals, Inc.
|
|
1,656,137 |
1,236,368 |
|
|
|
2020-02-13 |
13G/A
|
ADMS / Adamas Pharmaceuticals Inc
|
|
2,614,468 |
0 |
|
|
|
2020-02-13 |
13G/A
|
ACRS / Aclaris Therapeutics, Inc.
|
|
2,280,260 |
1,888,039 |
|
|
|
2020-02-13 |
13G/A
|
SBBP / Strongbridge Biopharma plc
|
|
2,821,722 |
600,000 |
|
|
|
2020-02-13 |
13G/A
|
TLGT / Teligent Inc
|
|
2,823,383 |
0 |
|
|
|
2020-02-13 |
13G/A
|
SRRA / Sierra Oncology Inc
|
|
4,880,327 |
0 |
|
|
|
2020-02-13 |
13G/A
|
LJPC / La Jolla Pharmaceutical Co.
|
|
1,947,541 |
2,688,068 |
|
|
|
2020-02-13 |
13G/A
|
AVDL / Avadel Pharmaceuticals plc
|
|
3,102,673 |
1,029,012 |
|
|
|
2020-02-13 |
13G/A
|
ADMA / ADMA Biologics, Inc.
|
|
4,226,077 |
0 |
|
|
|
2020-02-13 |
13G/A
|
ZCOR / Zyla Life Sciences
|
|
|
0 |
|
|
|
2020-02-13 |
13G/A
|
CPRX / Catalyst Pharmaceuticals, Inc.
|
|
6,268,298 |
0 |
|
|
|
2020-02-13 |
13G/A
|
REPH / Societal CDMO Inc
|
|
2,048,025 |
721,073 |
|
|
|
2020-01-23 |
13D/A
|
SSKN / STRATA Skin Sciences, Inc.
|
|
2,170,757 |
2,170,757 |
|
|
|
2020-01-22 |
13D/A
|
SSKN / STRATA Skin Sciences, Inc.
|
|
2,964,180 |
2,170,757 |
|
|
|
2020-01-15 |
13G/A
|
NVLN / NOVELION THERAPEUTICS INC.
|
|
1,934,923 |
2,541,222 |
|
|
|
2019-12-23 |
13D/A
|
BDSI / Biodelivery Sciences International
|
|
5,923,325 |
6,732,911 |
|
|
|
2019-11-18 |
13D/A
|
SSKN / STRATA Skin Sciences, Inc.
|
|
|
2,964,180 |
|
|
|
2019-10-07 |
13G/A
|
AVDL / Avadel Pharmaceuticals plc
|
|
3,102,673 |
3,102,673 |
|
|
|
2019-10-04 |
13D/A
|
AVDL / Avadel Pharmaceuticals plc
|
|
3,102,673 |
3,102,673 |
|
|
|
2019-07-22 |
13G/A
|
PETX / Aratana Therapeutics, Inc.
|
|
7,258,135 |
0 |
|
|
|
2019-07-19 |
13G
|
TVTX / Travere Therapeutics, Inc.
|
|
1,915,991 |
2,077,432 |
|
|
|
2019-06-14 |
13G
|
EIGR / Eiger BioPharmaceuticals, Inc.
|
|
|
1,656,137 |
|
|
|
2019-02-13 |
13G/A
|
SBBP / Strongbridge Biopharma plc
|
|
3,786,695 |
2,821,722 |
|
|
|
2019-02-13 |
13G/A
|
MRTX / Mirati Therapeutics, Inc.
|
|
2,447,746 |
200,000 |
|
|
|
2019-02-13 |
13G/A
|
LJPC / La Jolla Pharmaceutical Co.
|
|
1,029,866 |
1,947,541 |
|
|
|
2019-02-13 |
13G/A
|
SRRA / Sierra Oncology Inc
|
|
4,090,344 |
4,880,327 |
|
|
|
2019-02-13 |
13G/A
|
ADMA / ADMA Biologics, Inc.
|
|
3,249,829 |
4,226,077 |
|
|
|
2019-02-13 |
13G/A
|
CPRX / Catalyst Pharmaceuticals, Inc.
|
|
7,097,300 |
6,268,298 |
|
|
|
2019-02-13 |
13G/A
|
ADMS / Adamas Pharmaceuticals Inc
|
|
1,439,553 |
2,614,468 |
|
|
|
2019-02-13 |
13G/A
|
TLGT / Teligent Inc
|
|
2,999,817 |
2,823,383 |
|
|
|
2019-02-13 |
13G/A
|
IOVA / Iovance Biotherapeutics, Inc.
|
|
5,091,160 |
5,951,153 |
|
|
|
2019-02-11 |
13G
|
ZCOR / Zyla Life Sciences
|
|
|
696,657 |
|
|
|
2019-02-07 |
13G/A
|
ZCOR / Zyla Life Sciences
|
|
4,775,756 |
0 |
|
|
|
2019-01-29 |
13G
|
ACRS / Aclaris Therapeutics, Inc.
|
|
|
2,280,260 |
|
|
|
2019-01-22 |
13G/A
|
PETX / Aratana Therapeutics, Inc.
|
|
4,294,426 |
7,258,135 |
|
|
|
2019-01-03 |
13G
|
US64052L1061 / Neos Therapeutics, Inc.
|
|
|
2,618,819 |
|
|
|
2018-12-27 |
13G/A
|
NVLN / NOVELION THERAPEUTICS INC.
|
|
1,948,554 |
1,934,923 |
|
|
|
2018-12-11 |
13D
|
AVDL / Avadel Pharmaceuticals plc
|
|
2,591,721 |
3,102,673 |
|
|
|
2018-11-28 |
13G/A
|
CORI / Corium International, Inc.
|
|
4,474,995 |
0 |
|
|
|
2018-10-15 |
13G/A
|
CORI / Corium International, Inc.
|
|
3,432,326 |
4,474,995 |
|
|
|
2018-09-07 |
13G
|
SRRA / Sierra Oncology Inc
|
|
|
4,090,344 |
|
|
|
2018-08-08 |
13D/A
|
BDSI / Biodelivery Sciences International
|
|
4,278,819 |
5,923,325 |
|
|
|
2018-06-11 |
13G
|
ADMA / ADMA Biologics, Inc.
|
|
1,102,200 |
3,249,829 |
|
|
|
2018-05-24 |
13G/A
|
REPH / Societal CDMO Inc
|
|
2,236,025 |
2,048,025 |
|
|
|
2018-05-21 |
13D/A
|
BDSI / Biodelivery Sciences International
|
|
4,278,819 |
4,278,819 |
|
|
|
2018-05-01 |
13G
|
TLGT / Teligent Inc
|
|
|
2,999,817 |
|
|
|
2018-05-01 |
13D/A
|
BDSI / Biodelivery Sciences International
|
|
4,278,819 |
4,278,819 |
|
|
|
2018-04-24 |
13G
|
ADMS / Adamas Pharmaceuticals Inc
|
|
|
1,439,553 |
|
|
|
2018-04-10 |
13D
|
BDSI / Biodelivery Sciences International
|
|
4,278,819 |
4,278,819 |
|
|
|
2018-04-09 |
13D
|
BDSI / Biodelivery Sciences International
|
|
4,634,119 |
4,278,819 |
|
|
|
2018-03-20 |
13D/A
|
NVLN / NOVELION THERAPEUTICS INC.
|
|
|
1,948,554 |
|
|
|
2018-03-15 |
13D/A
|
REPH / Societal CDMO Inc
|
|
|
2,236,025 |
|
|
|
2018-02-14 |
13G/A
|
CRDC / Cardica, Inc.
|
|
898,053 |
0 |
|
|
|
2018-02-13 |
13G
|
ARCT / Arcturus Therapeutics Holdings Inc.
|
|
2,057,106 |
0 |
|
|
|
2018-02-13 |
13G/A
|
DRRX / DURECT Corporation
|
|
8,506,229 |
0 |
|
|
|
2018-02-13 |
13G/A
|
451731103 / Ignyta, Inc.
|
|
2,256,546 |
1,150,119 |
|
|
|
2018-02-13 |
13G/A
|
ATEC / Alphatec Holdings, Inc.
|
|
1,164,618 |
145,514 |
|
|
|
2018-02-13 |
13G/A
|
CORI / Corium International, Inc.
|
|
4,436,726 |
3,432,326 |
|
|
|
2018-02-13 |
13G/A
|
TVTX / Travere Therapeutics, Inc.
|
|
3,491,494 |
1,915,991 |
|
|
|
2018-02-13 |
13G/A
|
WINT / Windtree Therapeutics, Inc.
|
|
11,116,965 |
145,387 |
|
|
|
2018-02-13 |
13G/A
|
CFRX / ContraFect Corp
|
|
2,938,329 |
3,540,886 |
|
|
|
2018-02-13 |
13G/A
|
PGNX / Progenics Pharmaceuticals, Inc.
|
|
8,951,169 |
0 |
|
|
|
2018-02-13 |
13G/A
|
ADMA / ADMA Biologics, Inc.
|
|
1,113,293 |
1,102,200 |
|
|
|
2018-02-13 |
13G/A
|
SPNE / SeaSpine Holdings Corp
|
|
1,100,007 |
0 |
|
|
|
2018-02-13 |
13G/A
|
PETX / Aratana Therapeutics, Inc.
|
|
4,455,442 |
4,294,426 |
|
|
|
2018-02-13 |
13G/A
|
AVDL / Avadel Pharmaceuticals plc
|
|
4,394,464 |
2,591,721 |
|
|
|
2018-02-13 |
13G
|
ADHD / Alcobra Ltd.
|
|
|
0 |
|
|
|
2018-02-13 |
13G/A
|
RGLS / Regulus Therapeutics Inc.
|
|
5,494,505 |
1,509,342 |
|
|
|
2018-02-13 |
13G/A
|
BDSI / Biodelivery Sciences International
|
|
5,398,794 |
4,634,119 |
|
|
|
2018-02-13 |
13G/A
|
TENX / Tenax Therapeutics, Inc.
|
|
|
0 |
|
|
|
2018-02-13 |
13G/A
|
SCYX / SCYNEXIS, Inc.
|
|
1,803,523 |
326,250 |
|
|
|
2018-02-13 |
13G/A
|
CPRX / Catalyst Pharmaceuticals, Inc.
|
|
8,200,000 |
7,097,300 |
|
|
|
2018-02-13 |
13G/A
|
ATRS / Antares Pharma Inc
|
|
12,971,093 |
4,535,647 |
|
|
|
2018-02-13 |
13G/A
|
NVET / Nexvet Biopharma plc
|
|
1,127,200 |
0 |
|
|
|
2018-02-13 |
13G/A
|
VXRT / Vaxart, Inc.
|
|
3,486,711 |
0 |
|
|
|
2018-02-13 |
13G/A
|
CDTX / Cidara Therapeutics, Inc.
|
|
888,062 |
857,397 |
|
|
|
2018-02-13 |
13G/A
|
MRTX / Mirati Therapeutics, Inc.
|
|
2,728,601 |
2,447,746 |
|
|
|
2018-02-13 |
13G/A
|
MDGN / Medgenics, Inc.
|
|
3,370,306 |
0 |
|
|
|
2018-02-13 |
13G/A
|
HRTX / Heron Therapeutics, Inc.
|
|
3,916,534 |
2,428,518 |
|
|
|
2018-02-13 |
13G
|
IOVA / Iovance Biotherapeutics, Inc.
|
|
5,388,808 |
5,091,160 |
|
|
|
2018-02-13 |
13G/A
|
SBBP / Strongbridge Biopharma plc
|
|
3,494,581 |
3,786,695 |
|
|
|
2018-02-13 |
13G/A
|
VCYT / Veracyte, Inc.
|
|
1,788,266 |
746,358 |
|
|
|
2018-02-13 |
13G/A
|
ARLZ / Aralez Pharmaceuticals Inc.
|
|
4,791,590 |
0 |
|
|
|
2018-01-11 |
13G
|
LJPC / La Jolla Pharmaceutical Co.
|
|
1,510,316 |
1,108,239 |
|
|
|
2018-01-11 |
13G/A
|
LJPC / La Jolla Pharmaceutical Co.
|
|
1,510,316 |
1,029,866 |
|
|
|
2018-01-03 |
13G
|
ZCOR / Zyla Life Sciences
|
|
1,228,751 |
4,775,756 |
|
|
|
2017-12-14 |
13D/A
|
REPH / Societal CDMO Inc
|
|
2,705,262 |
2,512,025 |
|
|
|
2017-12-04 |
13D/A
|
REPH / Societal CDMO Inc
|
|
|
2,705,262 |
|
|
|
2017-11-24 |
13D/A
|
REPH / Societal CDMO Inc
|
|
3,100,086 |
2,927,878 |
|
|
|
2017-11-20 |
13G/A
|
MRTX / Mirati Therapeutics, Inc.
|
|
1,676,001 |
2,728,601 |
|
|
|
2017-07-24 |
13G
|
RGLS / Regulus Therapeutics Inc.
|
|
|
5,494,505 |
|
|
|
2017-07-13 |
13G
|
CDTX / Cidara Therapeutics, Inc.
|
|
|
888,062 |
|
|
|
2017-05-25 |
13G/A
|
CORI / Corium International, Inc.
|
|
1,919,721 |
4,436,726 |
|
|
|
2017-05-11 |
13G/A
|
PETX / Aratana Therapeutics, Inc.
|
|
3,695,442 |
4,455,442 |
|
|
|
2017-03-29 |
13G
|
ATEC / Alphatec Holdings, Inc.
|
|
|
1,164,618 |
|
|
|
2017-02-13 |
13G/A
|
MDGN / Medgenics, Inc.
|
|
|
3,370,306 |
|
|
|
2017-02-13 |
13G/A
|
VXRT / Vaxart, Inc.
|
|
3,486,711 |
3,486,711 |
|
|
|
2017-02-13 |
13G/A
|
ANGO / AngioDynamics, Inc.
|
|
2,498,527 |
1,471,152 |
|
|
|
2017-02-13 |
13G/A
|
VXRT / Vaxart, Inc.
|
|
|
3,486,711 |
|
|
|
2017-02-13 |
13G/A
|
ARLZ / Aralez Pharmaceuticals Inc.
|
|
3,800,000 |
4,791,590 |
|
|
|
2017-02-13 |
13G/A
|
ARCT / Arcturus Therapeutics Holdings Inc.
|
|
1,557,106 |
2,057,106 |
|
|
|
2017-02-13 |
13G/A
|
ARMP / Armata Pharmaceuticals, Inc.
|
|
585,814 |
68,000 |
|
|
|
2017-02-13 |
13G/A
|
PETX / Aratana Therapeutics, Inc.
|
|
3,428,865 |
3,695,442 |
|
|
|
2017-02-13 |
13G/A
|
BDSI / Biodelivery Sciences International
|
|
5,188,794 |
5,398,794 |
|
|
|
2017-02-13 |
13G/A
|
451731103 / Ignyta, Inc.
|
|
2,256,546 |
2,256,546 |
|
|
|
2017-02-13 |
13G/A
|
PGNX / Progenics Pharmaceuticals, Inc.
|
|
8,951,169 |
8,951,169 |
|
|
|
2017-02-13 |
13G/A
|
VCYT / Veracyte, Inc.
|
|
1,916,666 |
1,788,266 |
|
|
|
2017-02-13 |
13G/A
|
BLRX / BioLineRx Ltd. - Depositary Receipt (Common Stock)
|
|
350,000,004 |
0 |
|
|
|
2017-02-13 |
13G/A
|
NVRO / Nevro Corp.
|
|
1,462,564 |
43,281 |
|
|
|
2017-02-13 |
13G/A
|
CPRX / Catalyst Pharmaceuticals, Inc.
|
|
4,183,177 |
8,200,000 |
|
|
|
2017-02-13 |
13G/A
|
ZCOR / Zyla Life Sciences
|
|
1,807,244 |
1,228,751 |
|
|
|
2017-02-13 |
13G/A
|
ADMA / ADMA Biologics, Inc.
|
|
964,193 |
1,113,293 |
|
|
|
2017-02-13 |
13G/A
|
ATRS / Antares Pharma Inc
|
|
11,475,000 |
12,971,093 |
|
|
|
2017-02-13 |
13G/A
|
PHIO / Phio Pharmaceuticals Corp.
|
|
6,617,138 |
250,000 |
|
|
|
2017-02-13 |
13G/A
|
ADXS / Ayala Pharmaceuticals, Inc.
|
|
1,690,517 |
1,519,259 |
|
|
|
2017-02-10 |
13G/A
|
PTX / Pernix Therapeutics Holdings, Inc.
|
|
6,090,829 |
0 |
|
|
|
2017-02-10 |
13G/A
|
KMPH / Zevra Therapeutics Inc
|
|
732,338 |
0 |
|
|
|
2017-02-10 |
13G/A
|
SCYX / SCYNEXIS, Inc.
|
|
775,000 |
1,803,523 |
|
|
|
2017-02-10 |
13G/A
|
TVTX / Travere Therapeutics, Inc.
|
|
3,679,489 |
3,491,494 |
|
|
|
2017-02-10 |
13G/A
|
HZNP / Horizon Therapeutics Plc
|
|
8,631,310 |
6,759,819 |
|
|
|
2017-02-10 |
13G/A
|
QLGN / Qualigen Therapeutics, Inc.
|
|
778,000 |
0 |
|
|
|
2017-02-10 |
13G/A
|
TNXP / Tonix Pharmaceuticals Holding Corp.
|
|
1,243,748 |
353,000 |
|
|
|
2017-02-10 |
13G
|
CRDC / Cardica, Inc.
|
|
888,499 |
898,053 |
|
|
|
2017-02-10 |
13G/A
|
RDHL / RedHill Biopharma Ltd. - Depositary Receipt (Common Stock)
|
|
93,517,004 |
356,773 |
|
|
|
2017-02-10 |
13G/A
|
CORI / Corium International, Inc.
|
|
1,802,092 |
1,919,721 |
|
|
|
2017-02-10 |
13G/A
|
NVET / Nexvet Biopharma plc
|
|
721,595 |
1,127,200 |
|
|
|
2017-02-10 |
13G/A
|
SBBP / Strongbridge Biopharma plc
|
|
1,656,705 |
3,494,581 |
|
|
|
2017-02-10 |
13G/A
|
SPNE / SeaSpine Holdings Corp
|
|
1,000,007 |
1,100,007 |
|
|
|
2017-02-10 |
13G/A
|
CASM / CAS Medical Systems, Inc.
|
|
2,618,296 |
0 |
|
|
|
2017-02-10 |
13G/A
|
TTNP / Titan Pharmaceuticals, Inc.
|
|
1,579,383 |
0 |
|
|
|
2017-02-10 |
13G/A
|
LJPC / La Jolla Pharmaceutical Co.
|
|
1,165,373 |
1,510,316 |
|
|
|
2017-02-10 |
13G
|
WINT / Windtree Therapeutics, Inc.
|
|
|
854,409 |
|
|
|
2017-02-10 |
13G/A
|
CFRX / ContraFect Corp
|
|
2,127,659 |
2,938,329 |
|
|
|
2017-02-10 |
13G/A
|
IOVA / Iovance Biotherapeutics, Inc.
|
|
3,605,519 |
5,388,808 |
|
|
|
2017-02-10 |
13G/A
|
HRTX / Heron Therapeutics, Inc.
|
|
3,298,668 |
3,916,534 |
|
|
|
2017-02-10 |
13G/A
|
NVDQ / ETF Opportunities Trust - T-Rex 2X Inverse NVIDIA Daily Target ETF
|
|
4,449,180 |
407,188 |
|
|
|
2017-01-13 |
13D/A
|
DSCI / Derma Sciences, Inc.
|
|
2,562,104 |
0 |
|
|
|
2017-01-09 |
13G
|
MRTX / Mirati Therapeutics, Inc.
|
|
1,000,000 |
1,676,001 |
|
|
|
2017-01-09 |
13G/A
|
MRTX / Mirati Therapeutics, Inc.
|
|
1,000,000 |
826,001 |
|
|
|
2017-01-06 |
13G
|
AVDL / Avadel Pharmaceuticals plc
|
|
4,394,464 |
4,394,464 |
|
|
|
2017-01-06 |
13G/A
|
AVDL / Avadel Pharmaceuticals plc
|
|
4,394,464 |
0 |
|
|
|
2016-12-14 |
13D/A
|
REPH / Societal CDMO Inc
|
|
|
3,100,086 |
|
|
|
2016-12-01 |
13D/A
|
AEGR / Aegerion Pharmaceuticals, Inc.
|
|
|
0 |
|
|
|
2016-12-01 |
13D/A
|
NVLN / NOVELION THERAPEUTICS INC.
|
|
5,269,831 |
9,742,770 |
|
|
|
2016-11-21 |
13G
|
DRRX / DURECT Corporation
|
|
|
8,506,229 |
|
|
|
2016-11-04 |
13G
|
VCYT / Veracyte, Inc.
|
|
|
1,916,666 |
|
|
|
2016-09-22 |
13D/A
|
NVLN / NOVELION THERAPEUTICS INC.
|
|
4,445,527 |
5,269,831 |
|
|
|
2016-09-13 |
13D/A
|
AEGR / Aegerion Pharmaceuticals, Inc.
|
|
|
4,286,291 |
|
|
|
2016-09-13 |
13D/A
|
NVLN / NOVELION THERAPEUTICS INC.
|
|
|
4,445,527 |
|
|
|
2016-09-12 |
13D/A
|
QLTI / The 2023 ETF Series Trust II - GMO International Quality ETF
|
|
|
4,445,527 |
|
|
|
2016-09-12 |
13D/A
|
AEGR / Aegerion Pharmaceuticals, Inc.
|
|
|
|
|
|
|
2016-08-17 |
13D/A
|
REPH / Societal CDMO Inc
|
|
2,060,086 |
2,450,086 |
|
|
|
2016-08-10 |
13G
|
MRTX / Mirati Therapeutics, Inc.
|
|
|
1,000,000 |
|
|
|
2016-06-22 |
13D
|
AEGR / Aegerion Pharmaceuticals, Inc.
|
|
4,010,291 |
4,010,291 |
|
|
|
2016-06-22 |
13D
|
NVLN / NOVELION THERAPEUTICS INC.
|
|
4,445,527 |
4,445,527 |
|
|
|
2016-03-24 |
13G
|
ARLZ / Aralez Pharmaceuticals Inc.
|
|
|
3,800,000 |
|
|
|
2016-03-15 |
13D/A
|
SSKN / STRATA Skin Sciences, Inc.
|
|
|
1,008,297 |
|
|
|
2016-03-08 |
13G/A
|
PTX / Pernix Therapeutics Holdings, Inc.
|
|
11,116,965 |
6,090,829 |
|
|
|
2016-03-01 |
13G
|
NVRO / Nevro Corp.
|
|
1,201,480 |
1,462,564 |
|
|
|
2016-02-26 |
13G
|
CRDC / Cardica, Inc.
|
|
8,874,992 |
888,499 |
|
|
|
2016-02-16 |
13G/A
|
SESN / Sesen Bio Inc.
|
|
|
54,450 |
|
|
|
2016-02-16 |
13G/A
|
SESN / Sesen Bio Inc.
|
|
|
54,450 |
|
|
|
2016-02-16 |
13G/A
|
KMPH / Zevra Therapeutics Inc
|
|
802,400 |
732,338 |
|
|
|
2016-02-16 |
13G/A
|
CFRX / ContraFect Corp
|
|
1,418,440 |
2,127,659 |
|
|
|
2016-02-16 |
13G/A
|
PGNX / Progenics Pharmaceuticals, Inc.
|
|
|
8,951,169 |
|
|
|
2016-02-16 |
13G/A
|
NVDQ / ETF Opportunities Trust - T-Rex 2X Inverse NVIDIA Daily Target ETF
|
|
3,958,648 |
4,449,180 |
|
|
|
2016-02-16 |
13G/A
|
NBSE / NeuBase Therapeutics, Inc.
|
|
1,775,000 |
0 |
|
|
|
2016-02-12 |
13G/A
|
VXRT / Vaxart, Inc.
|
|
|
3,486,711 |
|
|
|
2016-02-12 |
13G/A
|
ANTH / Anthera Pharmaceuticals, Inc.
|
|
|
1,154,674 |
|
|
|
2016-02-12 |
13G/A
|
VXRT / Vaxart, Inc.
|
|
|
3,486,711 |
|
|
|
2016-02-12 |
13G/A
|
HRTX / Heron Therapeutics, Inc.
|
|
|
3,298,668 |
|
|
|
2016-02-12 |
13G/A
|
EPRSQ / Epirus Biopharmaceuticals Inc
|
|
|
1,375,000 |
|
|
|
2016-02-12 |
13G/A
|
TNXP / Tonix Pharmaceuticals Holding Corp.
|
|
|
1,243,748 |
|
|
|
2016-02-12 |
13G/A
|
KALV / KalVista Pharmaceuticals, Inc.
|
|
1,250,000 |
1,178,941 |
|
|
|
2016-02-12 |
13G/A
|
ANTH / Anthera Pharmaceuticals, Inc.
|
|
|
1,154,674 |
|
|
|
2016-02-12 |
13G/A
|
ZGNX / Zogenix Inc
|
|
10,737,645 |
1,087,112 |
|
|
|
2016-02-12 |
13G/A
|
EBS / Emergent BioSolutions Inc.
|
|
|
672,922 |
|
|
|
2016-02-12 |
13G/A
|
ALBO / Albireo Pharma Inc
|
|
|
2,000,000 |
|
|
|
2016-02-12 |
13G/A
|
ADXS / Ayala Pharmaceuticals, Inc.
|
|
1,655,314 |
1,690,517 |
|
|
|
2016-02-12 |
13G/A
|
PLXP / PLx Pharma Inc.
|
|
|
465,978 |
|
|
|
2016-02-12 |
13G/A
|
TVTX / Travere Therapeutics, Inc.
|
|
|
3,679,489 |
|
|
|
2016-02-12 |
13G/A
|
PETX / Aratana Therapeutics, Inc.
|
|
1,809,865 |
3,428,865 |
|
|
|
2016-02-12 |
13G/A
|
BDSI / Biodelivery Sciences International
|
|
3,894,060 |
5,188,794 |
|
|
|
2016-02-12 |
13G/A
|
NVRO / Nevro Corp.
|
|
1,607,085 |
1,201,480 |
|
|
|
2016-02-12 |
13G/A
|
GNMX / Aevi Genomic Medicine, Inc.
|
|
1,475,200 |
3,045,306 |
|
|
|
2016-02-12 |
13G/A
|
BLRX / BioLineRx Ltd. - Depositary Receipt (Common Stock)
|
|
310,000,004 |
35,000,000 |
|
|
|
2016-02-12 |
13G/A
|
HZNP / Horizon Therapeutics Plc
|
|
|
8,631,310 |
|
|
|
2016-02-12 |
13G/A
|
PHIO / Phio Pharmaceuticals Corp.
|
|
|
6,617,138 |
|
|
|
2016-02-12 |
13G/A
|
AKTX / Akari Therapeutics, Plc - Depositary Receipt (Common Stock)
|
|
|
0 |
|
|
|
2016-02-12 |
13G/A
|
RDHL / RedHill Biopharma Ltd. - Depositary Receipt (Common Stock)
|
|
|
9,351,700 |
|
|
|
2016-02-12 |
13G/A
|
451731103 / Ignyta, Inc.
|
|
1,516,700 |
2,256,546 |
|
|
|
2016-02-12 |
13G/A
|
CORI / Corium International, Inc.
|
|
|
1,802,092 |
|
|
|
2016-02-12 |
13G/A
|
NVET / Nexvet Biopharma plc
|
|
700,000 |
721,595 |
|
|
|
2016-02-12 |
13G/A
|
SPNE / SeaSpine Holdings Corp
|
|
900,304 |
1,000,007 |
|
|
|
2016-02-12 |
13G/A
|
CASM / CAS Medical Systems, Inc.
|
|
|
2,618,296 |
|
|
|
2016-02-12 |
13G/A
|
TTNP / Titan Pharmaceuticals, Inc.
|
|
|
1,579,383 |
|
|
|
2016-02-12 |
13G/A
|
LJPC / La Jolla Pharmaceutical Co.
|
|
|
1,165,373 |
|
|
|
2016-02-12 |
13G/A
|
ARMP / Armata Pharmaceuticals, Inc.
|
|
|
585,814 |
|
|
|
2016-02-12 |
13G/A
|
WINT / Windtree Therapeutics, Inc.
|
|
|
11,116,965 |
|
|
|
2016-02-12 |
13G/A
|
PTX / Pernix Therapeutics Holdings, Inc.
|
|
|
11,116,965 |
|
|
|
2016-02-12 |
13G/A
|
ATRS / Antares Pharma Inc
|
|
8,017,488 |
11,475,000 |
|
|
|
2016-02-12 |
13G/A
|
AVDL / Avadel Pharmaceuticals plc
|
|
|
4,394,464 |
|
|
|
2016-02-11 |
13G
|
ZCOR / Zyla Life Sciences
|
|
|
1,807,244 |
|
|
|
2016-02-11 |
13G/A
|
ARCT / Arcturus Therapeutics Holdings Inc.
|
|
|
1,557,106 |
|
|
|
2016-02-11 |
13G
|
IOVA / Iovance Biotherapeutics, Inc.
|
|
|
3,605,519 |
|
|
|
2016-02-11 |
13G/A
|
CPRX / Catalyst Pharmaceuticals, Inc.
|
|
|
4,183,177 |
|
|
|
2016-02-11 |
13G/A
|
ANGO / AngioDynamics, Inc.
|
|
|
2,498,527 |
|
|
|
2016-02-11 |
13G/A
|
RIGL / Rigel Pharmaceuticals, Inc.
|
|
|
3,125,282 |
|
|
|
2016-01-28 |
13G
|
RPTP / Raptor Pharmaceutical Corp.
|
|
|
7,518,281 |
|
|
|
2016-01-13 |
13G
|
SBBP / Strongbridge Biopharma plc
|
|
|
1,656,705 |
|
|
|
2015-12-28 |
13G
|
NVET / Nexvet Biopharma plc
|
|
|
700,000 |
|
|
|
2015-12-16 |
13D/A
|
DSCI / Derma Sciences, Inc.
|
|
|
2,562,104 |
|
|
|
2015-11-13 |
13G/A
|
AEGR / Aegerion Pharmaceuticals, Inc.
|
|
|
4,010,291 |
|
|
|
2015-11-03 |
13G
|
PETX / Aratana Therapeutics, Inc.
|
|
|
1,809,865 |
|
|
|
2015-10-29 |
13G
|
NVDQ / ETF Opportunities Trust - T-Rex 2X Inverse NVIDIA Daily Target ETF
|
|
|
3,958,648 |
|
|
|
2015-09-24 |
13G
|
NVRO / Nevro Corp.
|
|
|
1,607,085 |
|
|
|
2015-09-11 |
13D/A
|
DXTR / Dextera Surgical Inc.
|
|
8,874,992 |
8,874,992 |
|
|
|
2015-09-09 |
13G
|
ATRS / Antares Pharma Inc
|
|
|
8,017,488 |
|
|
|
2015-09-04 |
13D
|
DXTR / Dextera Surgical Inc.
|
|
8,874,992 |
8,874,992 |
|
|
|
2015-08-24 |
13D/A
|
MELA / MELA Sciences, Inc
|
|
|
1,274,297 |
|
|
|
2015-08-12 |
13G
|
ADXS / Ayala Pharmaceuticals, Inc.
|
|
|
1,655,314 |
|
|
|
2015-07-21 |
13G
|
SPNE / SeaSpine Holdings Corp
|
|
|
900,304 |
|
|
|
2015-07-16 |
13G
|
GNMX / Aevi Genomic Medicine, Inc.
|
|
|
1,475,200 |
|
|
|
2015-07-15 |
13D
|
REPH / Societal CDMO Inc
|
|
|
2,060,086 |
|
|
|
2015-07-01 |
13G
|
QLGN / Qualigen Therapeutics, Inc.
|
|
|
778,000 |
|
|
|
2015-06-25 |
13G
|
NVLN / NOVELION THERAPEUTICS INC.
|
|
|
4,445,527 |
|
|
|
2015-06-17 |
13G
|
CFRX / ContraFect Corp
|
|
|
1,418,440 |
|
|
|
2015-05-27 |
13G
|
SCYX / SCYNEXIS, Inc.
|
|
|
775,000 |
|
|
|
2015-05-20 |
13G
|
BDSI / Biodelivery Sciences International
|
|
|
3,894,060 |
|
|
|
2015-04-29 |
13G
|
KMPH / Zevra Therapeutics Inc
|
|
|
802,400 |
|
|
|
2015-04-14 |
13G
|
KALV / KalVista Pharmaceuticals, Inc.
|
|
|
1,250,000 |
|
|
|
2015-04-07 |
13G
|
NBSE / NeuBase Therapeutics, Inc.
|
|
|
1,775,000 |
|
|
|
2015-03-25 |
13G
|
DXTR / Dextera Surgical Inc.
|
|
|
8,874,992 |
|
|
|
2015-03-24 |
13G
|
451731103 / Ignyta, Inc.
|
|
|
1,516,700 |
|
|
|
2015-03-20 |
13D/A
|
DSCI / Derma Sciences, Inc.
|
|
2,130,477 |
|
|
|
|
2015-03-19 |
13G
|
ADMA / ADMA Biologics, Inc.
|
|
|
964,193 |
|
|
|
2015-03-18 |
13D
|
DSCI / Derma Sciences, Inc.
|
|
|
2,130,477 |
|
|
|
2015-03-18 |
13G
|
ZGNX / Zogenix Inc
|
|
|
10,737,645 |
|
|
|
2015-03-16 |
13G
|
BLRX / BioLineRx Ltd. - Depositary Receipt (Common Stock)
|
|
|
31,000,000 |
|
|
|
2015-02-26 |
13G
|
RDHL / RedHill Biopharma Ltd. - Depositary Receipt (Common Stock)
|
|
|
5,967,730 |
|
|
|
2015-02-17 |
13G
|
TNXP / Tonix Pharmaceuticals Holding Corp.
|
|
|
1,176,639 |
|
|
|
2015-02-17 |
13G
|
ALBO / Albireo Pharma Inc
|
|
|
1,330,034 |
|
|
|
2015-02-17 |
13G/A
|
CORI / Corium International, Inc.
|
|
|
1,736,736 |
|
|
|
2015-02-17 |
13G/A
|
AMPH / Amphastar Pharmaceuticals, Inc.
|
|
|
2,127,854 |
|
|
|
2015-02-17 |
13G/A
|
AVDL / Avadel Pharmaceuticals plc
|
|
|
5,153,190 |
|
|
|
2015-02-17 |
13G/A
|
REPH / Societal CDMO Inc
|
|
|
1,413,533 |
|
|
|
2015-02-17 |
13G/A
|
SESN / Sesen Bio Inc.
|
|
|
966,615 |
|
|
|
2015-02-17 |
13G/A
|
HRTX / Heron Therapeutics, Inc.
|
|
|
2,808,172 |
|
|
|
2015-02-17 |
13G/A
|
HZNP / Horizon Therapeutics Plc
|
|
|
8,917,975 |
|
|
|
2015-02-17 |
13G/A
|
RIGL / Rigel Pharmaceuticals, Inc.
|
|
|
8,501,750 |
|
|
|
2015-02-17 |
13G/A
|
TENX / Tenax Therapeutics, Inc.
|
|
|
1,968,631 |
|
|
|
2015-02-17 |
13G/A
|
AEGR / Aegerion Pharmaceuticals, Inc.
|
|
|
2,548,863 |
|
|
|
2015-02-17 |
13G/A
|
US00163U1060 / AMAG Pharmaceuticals, Inc.
|
|
|
573,530 |
|
|
|
2015-02-17 |
13G/A
|
ANTH / Anthera Pharmaceuticals, Inc.
|
|
|
1,783,812 |
|
|
|
2015-02-17 |
13G/A
|
TVTX / Travere Therapeutics, Inc.
|
|
|
2,549,874 |
|
|
|
2015-02-17 |
13G/A
|
TNXP / Tonix Pharmaceuticals Holding Corp.
|
|
|
501,639 |
|
|
|
2015-02-17 |
13G/A
|
LJPC / La Jolla Pharmaceutical Co.
|
|
|
1,121,370 |
|
|
|
2015-02-17 |
13G/A
|
EBS / Emergent BioSolutions Inc.
|
|
|
2,066,719 |
|
|
|
2015-02-17 |
13G/A
|
DSCI / Derma Sciences, Inc.
|
|
|
1,856,877 |
|
|
|
2015-02-17 |
13G/A
|
CLTX / Celsus Therapeutics
|
|
|
4,708,774 |
|
|
|
2015-02-17 |
13G/A
|
ASRT / Assertio Holdings, Inc.
|
|
|
1,713,702 |
|
|
|
2015-02-17 |
13G/A
|
CASM / CAS Medical Systems, Inc.
|
|
|
1,918,296 |
|
|
|
2015-02-17 |
13G/A
|
VXRT / Vaxart, Inc.
|
|
|
2,611,711 |
|
|
|
2015-02-17 |
13G/A
|
BDSI / Biodelivery Sciences International
|
|
|
2,396,399 |
|
|
|
2015-02-17 |
13G/A
|
IDRA / Idera Pharmaceuticals, Inc.
|
|
|
3,525,700 |
|
|
|
2015-02-17 |
13G/A
|
ANGO / AngioDynamics, Inc.
|
|
|
2,670,703 |
|
|
|
2015-02-13 |
13G
|
CPRX / Catalyst Pharmaceuticals, Inc.
|
|
|
4,083,177 |
|
|
|
2015-02-06 |
13G
|
EPRSQ / Epirus Biopharmaceuticals Inc
|
|
|
1,500,000 |
|
|
|
2015-01-16 |
13G
|
ARCT / Arcturus Therapeutics Holdings Inc.
|
|
|
1,379,806 |
|
|
|
2014-12-15 |
13D/A
|
DXTR / Dextera Surgical Inc.
|
|
|
8,874,992 |
|
|
|
2014-11-13 |
13D/A
|
DXTR / Dextera Surgical Inc.
|
|
|
|
|
|
|
2014-11-07 |
13G
|
AEGR / Aegerion Pharmaceuticals, Inc.
|
|
|
2,348,863 |
|
|
|
2014-10-10 |
13G
|
TTNP / Titan Pharmaceuticals, Inc.
|
|
|
6,372,500 |
|
|
|
2014-10-03 |
13G
|
ANTH / Anthera Pharmaceuticals, Inc.
|
|
|
1,301,622 |
|
|
|
2014-09-15 |
13G
|
REPH / Societal CDMO Inc
|
|
|
1,172,195 |
|
|
|
2014-09-11 |
13D/A
|
DXTR / Dextera Surgical Inc.
|
|
|
8,874,992 |
|
|
|
2014-08-08 |
13G
|
VXRT / Vaxart, Inc.
|
|
|
2,460,876 |
|
|
|
2014-07-24 |
13D
|
DXTR / Dextera Surgical Inc.
|
|
|
8,874,992 |
|
|
|
2014-07-21 |
13G/A
|
PGNX / Progenics Pharmaceuticals, Inc.
|
|
|
8,951,169 |
|
|
|
2014-07-03 |
13G
|
AMPH / Amphastar Pharmaceuticals, Inc.
|
|
|
2,175,000 |
|
|
|
2014-06-11 |
13G
|
TENX / Tenax Therapeutics, Inc.
|
|
|
1,518,631 |
|
|
|
2014-05-22 |
13G/A
|
DXTR / Dextera Surgical Inc.
|
|
|
8,374,992 |
|
|
|
2014-05-19 |
13G
|
EBS / Emergent BioSolutions Inc.
|
|
|
1,908,457 |
|
|
|
2014-04-16 |
13G
|
CORI / Corium International, Inc.
|
|
|
1,350,000 |
|
|
|
2014-04-16 |
13G
|
US00163U1060 / AMAG Pharmaceuticals, Inc.
|
|
|
1,427,117 |
|
|
|
2014-04-16 |
13G
|
LJPC / La Jolla Pharmaceutical Co.
|
|
|
389,921 |
|
|
|
2014-04-07 |
13G
|
PLXP / PLx Pharma Inc.
|
|
|
475,000 |
|
|
|
2014-04-03 |
13D/A
|
SSKN / STRATA Skin Sciences, Inc.
|
|
|
9,086,229 |
|
|
|
2014-03-13 |
13G
|
REPH / Societal CDMO Inc
|
|
|
580,000 |
|
|
|
2014-03-06 |
13G
|
PTX / Pernix Therapeutics Holdings, Inc.
|
|
|
3,500,000 |
|
|
|
2014-03-04 |
13D
|
SSKN / STRATA Skin Sciences, Inc.
|
|
|
9,086,229 |
|
|
|
2014-02-19 |
13G
|
SESN / Sesen Bio Inc.
|
|
|
896,100 |
|
|
|
2014-02-14 |
13G/A
|
US88165N2045 / Tetraphase Pharmaceuticals, Inc.
|
|
|
2,193,328 |
|
|
|
2014-02-14 |
13G/A
|
ALBO / Albireo Pharma Inc
|
|
|
1,000,000 |
|
|
|
2014-02-14 |
13G/A
|
ANGO / AngioDynamics, Inc.
|
|
|
2,497,049 |
|
|
|
2014-02-14 |
13G/A
|
ASMB / Assembly Biosciences, Inc.
|
|
|
1,849,839 |
|
|
|
2014-02-14 |
13G/A
|
BDSI / Biodelivery Sciences International
|
|
|
2,222,054 |
|
|
|
2014-02-14 |
13G/A
|
SLTM / Solta Medical Inc
|
|
|
3,356,391 |
|
|
|
2014-02-14 |
13G/A
|
HZNP / Horizon Therapeutics Plc
|
|
|
4,257,469 |
|
|
|
2014-02-14 |
13G/A
|
ASRT / Assertio Holdings, Inc.
|
|
|
4,744,772 |
|
|
|
2014-02-14 |
13G/A
|
DXTR / Dextera Surgical Inc.
|
|
|
4,772,672 |
|
|
|
2014-02-14 |
13G/A
|
ALQA / Alliqua, Inc.
|
|
|
696,864 |
|
|
|
2014-02-14 |
13G/A
|
AVDL / Avadel Pharmaceuticals plc
|
|
|
3,767,911 |
|
|
|
2014-02-14 |
13G/A
|
DRRX / DURECT Corporation
|
|
|
5,440,290 |
|
|
|
2014-02-14 |
13G/A
|
TNXP / Tonix Pharmaceuticals Holding Corp.
|
|
|
392,952 |
|
|
|
2014-02-14 |
13G/A
|
IPCI / Intellipharmaceutics International Inc.
|
|
|
0 |
|
|
|
2014-02-14 |
13G/A
|
PHIO / Phio Pharmaceuticals Corp.
|
|
|
1,126,482 |
|
|
|
2014-02-14 |
13G/A
|
LCI / Lannett Co., Inc.
|
|
|
1,339,945 |
|
|
|
2014-02-14 |
13G/A
|
CASM / CAS Medical Systems, Inc.
|
|
|
1,349,796 |
|
|
|
2014-02-14 |
13G/A
|
HRTX / Heron Therapeutics, Inc.
|
|
|
44,663,455 |
|
|
|
2014-02-14 |
13G/A
|
PGNX / Progenics Pharmaceuticals, Inc.
|
|
|
4,000,000 |
|
|
|
2014-02-14 |
13G/A
|
IDRA / Idera Pharmaceuticals, Inc.
|
|
|
3,550,000 |
|
|
|
2014-02-14 |
13G/A
|
NTUS / Natus Medical Inc
|
|
|
1,014,116 |
|
|
|
2014-02-14 |
13G/A
|
WINT / Windtree Therapeutics, Inc.
|
|
|
8,066,000 |
|
|
|
2014-02-03 |
13G
|
LBMH / Liberator Medical Holdings, Inc.
|
|
|
2,644,832 |
|
|
|
2014-01-17 |
13G
|
TVTX / Travere Therapeutics, Inc.
|
|
|
1,609,696 |
|
|
|
2014-01-03 |
13G
|
APHB / Ampliphi Biosciences Corp.
|
|
|
14,000,000 |
|
|
|
2013-12-27 |
13G
|
RIGL / Rigel Pharmaceuticals, Inc.
|
|
|
4,455,119 |
|
|
|
2013-12-20 |
13G
|
DSCI / Derma Sciences, Inc.
|
|
|
871,598 |
|
|
|
2013-11-27 |
13G
|
HZNP / Horizon Therapeutics Plc
|
|
|
3,880,000 |
|
|
|
2013-11-27 |
13G
|
ALQA / Alliqua, Inc.
|
|
|
774,393 |
|
|
|
2013-10-17 |
13G
|
WINT / Windtree Therapeutics, Inc.
|
|
|
3,166,000 |
|
|
|
2013-10-07 |
13G
|
ALBO / Albireo Pharma Inc
|
|
|
1,000,000 |
|
|
|
2013-10-04 |
13G
|
AKTX / Akari Therapeutics, Plc - Depositary Receipt (Common Stock)
|
|
|
3,508,772 |
|
|
|
2013-10-04 |
13G
|
IDRA / Idera Pharmaceuticals, Inc.
|
|
|
4,525,000 |
|
|
|
2013-09-18 |
13G
|
CASM / CAS Medical Systems, Inc.
|
|
|
1,300,896 |
|
|
|
2013-08-14 |
13G
|
TNXP / Tonix Pharmaceuticals Holding Corp.
|
|
|
428,000 |
|
|
|
2013-06-13 |
13G/A
|
AVDL / Avadel Pharmaceuticals plc
|
|
|
2,981,507 |
|
|
|
2013-05-14 |
13G
|
DRRX / DURECT Corporation
|
|
|
5,331,927 |
|
|
|
2013-03-27 |
13G
|
US88165N2045 / Tetraphase Pharmaceuticals, Inc.
|
|
|
1,405,444 |
|
|
|
2013-03-27 |
13G
|
ASRT / Assertio Holdings, Inc.
|
|
|
2,824,503 |
|
|
|
2013-03-19 |
13G
|
DXTR / Dextera Surgical Inc.
|
|
|
4,285,715 |
|
|
|
2013-03-19 |
13G
|
PHIO / Phio Pharmaceuticals Corp.
|
|
|
31,034,483 |
|
|
|
2013-03-11 |
13G
|
BDSI / Biodelivery Sciences International
|
|
|
2,017,000 |
|
|
|
2013-02-14 |
13G/A
|
ANGO / AngioDynamics, Inc.
|
|
|
2,092,970 |
|
|
|
2013-02-14 |
13G/A
|
NVDQ / ETF Opportunities Trust - T-Rex 2X Inverse NVIDIA Daily Target ETF
|
|
|
1,744,794 |
|
|
|
2013-02-14 |
13G/A
|
AVDL / Avadel Pharmaceuticals plc
|
|
|
2,491,261 |
|
|
|
2013-02-14 |
13G/A
|
SNTS / Santarus, Inc
|
|
|
1,993,570 |
|
|
|
2013-02-14 |
13G/A
|
IPCI / Intellipharmaceutics International Inc.
|
|
|
1,728,221 |
|
|
|
2013-02-14 |
13G/A
|
LCI / Lannett Co., Inc.
|
|
|
2,560,419 |
|
|
|
2013-02-14 |
13G/A
|
INSV / Insite Vision Inc
|
|
|
13,171,866 |
|
|
|
2013-02-14 |
13G/A
|
NTUS / Natus Medical Inc
|
|
|
2,690,992 |
|
|
|
2013-02-04 |
13G
|
ASMB / Assembly Biosciences, Inc.
|
|
|
1,790,000 |
|
|
|
2012-12-31 |
13G
|
HRTX / Heron Therapeutics, Inc.
|
|
|
15,523,810 |
|
|
|
2012-12-10 |
13G
|
PGNX / Progenics Pharmaceuticals, Inc.
|
|
|
3,651,666 |
|
|
|
2012-09-28 |
13G
|
AVDL / Avadel Pharmaceuticals plc
|
|
|
1,300,000 |
|
|
|
2012-08-14 |
13G
|
SLTM / Solta Medical Inc
|
|
|
3,471,036 |
|
|
|
2012-05-22 |
13G
|
ANGO / AngioDynamics, Inc.
|
|
|
1,288,700 |
|
|
|
2012-04-10 |
13G
|
NVDQ / ETF Opportunities Trust - T-Rex 2X Inverse NVIDIA Daily Target ETF
|
|
|
2,102,263 |
|
|
|
2012-02-13 |
13G/A
|
SNTS / Santarus, Inc
|
|
|
4,600,100 |
|
|
|
2012-02-13 |
13G/A
|
IPCI / Intellipharmaceutics International Inc.
|
|
|
974,322 |
|
|
|
2012-02-13 |
13G/A
|
LCI / Lannett Co., Inc.
|
|
|
2,444,600 |
|
|
|
2012-02-13 |
13G/A
|
INSV / Insite Vision Inc
|
|
|
13,178,785 |
|
|
|
2012-02-13 |
13G/A
|
NTUS / Natus Medical Inc
|
|
|
1,710,227 |
|
|
|